Center for Cell and Gene Therapy, Baylor College of Medicine

• Vitamin C With Steroids for Gastrointestinal GVHD

  Collaborator, Early phase 1, Not yet recruiting, 35 people, 29 Sept 2025

• NCT02932956

  Collaborator, Phase 1, Active, not recruiting, 10 people, 13 Oct 2016

• NCT02905188

  Collaborator, Phase 1, Completed, 9 people, 19 Sept 2016

• HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

  Collaborator, Phase 1, Completed, 35 people, 5 Mar 2015

• NCT02287311

  Collaborator, Phase 1, Active, not recruiting, 38 people, 10 Nov 2014

• Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma

  Collaborator, Phase 1/2, Active, not recruiting, 11 people, 1 Sept 2010

• NCT00953420

  Collaborator, Phase 2, Completed, 20 people, 6 Aug 2009

• Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

  Collaborator, Phase 1, Active, not recruiting, 68 people, 10 Feb 2009

• NCT00579111

  Collaborator, Phase 1/2, Terminated, 4 people, 21 Dec 2007

• NCT00578903

  Collaborator, Phase 2, Terminated, 22 people, 21 Dec 2007

• NCT00058578

  Collaborator, Phase 1, Completed, 24 people, 9 Apr 2003

• NCT00057005

  Collaborator, Phase 1, Completed, 6 people, 28 Mar 2003

• NCT00056966

  Collaborator, Phase 1/2, Completed, 24 people, 27 Mar 2003

• NCT00040469

  Collaborator, Phase 2, Terminated, 15 people, 28 Jun 2002

Sources: clinicaltrials.gov